Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Gómez GY"'
Autor:
Cerisoli F; European Hematology Association, The Hague, The Netherlands., Ali F; Patient Health Impact, Pfizer, Montreal, Quebec, Canada., Bereczky T; Patvocates GmbH, Munich, Bayern, Germany., Bolaños N; Regional Management Europe, Lymphoma Coalition, Madrid, Spain., Bullinger L; Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt, Berlin, Germany., Dhanasiri S; Global Medical Affairs, Celgene International - A Bristol Myers Squibb Company, Boudry, Switzerland., Gallagher J; Pfizer Inc, New York, NY, USA., Pérez SG; Department of Medicines for Human Use, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain., Geissler J; Patvocates GmbH, Munich, Bayern, Germany., Guillevic Y; Global Medical Affairs, Celgene International - A Bristol Myers Squibb Company, Boudry, Switzerland., Harrison K; Science Policy and Research Programme, National Institute for Health and Care Excellence (NICE), Manchester, England, UK., Naoum A; European Hematology Association, The Hague, The Netherlands., Portulano C; Menarini Ricerche SpA, Florence, Italy., Rodríguez Vicente AE; Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain., Schulze-Rath R; Medical Affairs & Pharmacovigilance, Pharmaceuticals, Bayer AG, Berlin, Germany., Gómez GY; Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), Madrid, Spain., Sanz G; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain; Hospital Universitari i Politècnic la Fe, Valencia, Spain., Hernández Rivas JM; Servicio de Hematología, Instituto de Investigación Biomédica de Salamanca (IBSAL), Departamento de Medicina, Hospital Universitario de Salamanca, Universidad de Salamanca, Salamanca, Spain. Electronic address: jmhr@usal.es.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2022 Oct; Vol. 25 (10), pp. 1760-1767. Date of Electronic Publication: 2022 May 18.